Cargando…
Mechanisms and Drug Therapies of Bioprosthetic Heart Valve Calcification
Valve replacement is the main therapy for valvular heart disease, in which a diseased valve is replaced by mechanical heart valve (MHV) or bioprosthetic heart valve (BHV). Since the 2000s, BHV surpassed MHV as the leading option of prosthetic valve substitute because of its excellent hemocompatible...
Autores principales: | Wen, Shuyu, Zhou, Ying, Yim, Wai Yen, Wang, Shijie, Xu, Li, Shi, Jiawei, Qiao, Weihua, Dong, Nianguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204043/ https://www.ncbi.nlm.nih.gov/pubmed/35721165 http://dx.doi.org/10.3389/fphar.2022.909801 |
Ejemplares similares
-
Sevelamer Attenuates Bioprosthetic Heart Valve Calcification
por: Meng, Zhen, et al.
Publicado: (2021) -
Bioprosthetic vs mechanical mitral valve replacement for infective endocarditis in patients aged 50 to 69 years
por: Hu, Xingjian, et al.
Publicado: (2020) -
Bisphosphonates as Potential Inhibitors of Calcification in Bioprosthetic Heart Valves (Review)
por: Timchenko, T.P.
Publicado: (2022) -
Calcification and Oxidative Modifications Are Associated With Progressive Bioprosthetic Heart Valve Dysfunction
por: Lee, Suengwon, et al.
Publicado: (2017) -
Early bioprosthetic valve calcification with alfacalcidol supplementation
por: Takano, Tamaki, et al.
Publicado: (2013)